Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2
暂无分享,去创建一个
P. Neven | M. Karuturi | L. Schwartzberg | A. Joy | K. Gelmon | R. Mahtani | E. Bananis | P. Schnell | D. Lu | J. Walshe | Sindy T. Kim